Edition:
United Kingdom

Assembly Biosciences Inc (ASMB.OQ)

ASMB.OQ on NASDAQ Stock Exchange Capital Market

47.48USD
8:59pm GMT
Change (% chg)

$1.23 (+2.66%)
Prev Close
$46.25
Open
$46.26
Day's High
$49.24
Day's Low
$45.21
Volume
64,395
Avg. Vol
52,634
52-wk High
$52.37
52-wk Low
$18.02

Chart for

About

Assembly Biosciences, Inc. is a biotechnology company. The Company is engaged in developing two platform programs, such as a class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection, and a class of oral synthetic live therapeutics, which are designed to restore health to a dysbiotic microbiome. It has... (more)

Overall

Beta: 0.76
Market Cap(Mil.): $613.14
Shares Outstanding(Mil.): 17.36
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.58
EPS (TTM): -- -- --
ROI: -- 14.84 10.60
ROE: -- 16.32 14.19

BRIEF-Assembly Biosciences Files For Mixed Shelf Of Up To $250 Mln

* ASSEMBLY BIOSCIENCES FILES FOR MIXED SHELF OF UP TO $250 MILLION - SEC FILING Source text: (http://bit.ly/2CnCeGR) Further company coverage:

29 Dec 2017

BRIEF-Assembly Biosciences Appoints Sue Mahony To Board Of Directors

* ASSEMBLY BIOSCIENCES APPOINTS SUE MAHONY, PHD TO BOARD OF DIRECTORS

18 Dec 2017

BRIEF-Assembly Biosciences prices public offering of 2.21 mln common shares at $27.25 per share

* Assembly biosciences announces pricing of $60 million offering of common stock

02 Nov 2017

Competitors

  Price Chg
Kyowa Hakko Kirin Co Ltd (4151.T) ¥2,181 +22.00

Earnings vs. Estimates